341 related articles for article (PubMed ID: 20876211)
21. Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis.
Segura I; Serrano A; De Buitrago GG; González MA; Abad JL; Clavería C; Gómez L; Bernad A; Martínez-A C; Riese HH
FASEB J; 2002 Jun; 16(8):833-41. PubMed ID: 12039865
[TBL] [Abstract][Full Text] [Related]
22. Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.
Mader JS; Smyth D; Marshall J; Hoskin DW
Am J Pathol; 2006 Nov; 169(5):1753-66. PubMed ID: 17071598
[TBL] [Abstract][Full Text] [Related]
23. 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis requires STAT3-dependent expression of VEGF.
Srivastava K; Kundumani-Sridharan V; Zhang B; Bajpai AK; Rao GN
Cancer Res; 2007 May; 67(9):4328-36. PubMed ID: 17483346
[TBL] [Abstract][Full Text] [Related]
24. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
Scharpfenecker M; van Dinther M; Liu Z; van Bezooijen RL; Zhao Q; Pukac L; Löwik CW; ten Dijke P
J Cell Sci; 2007 Mar; 120(Pt 6):964-72. PubMed ID: 17311849
[TBL] [Abstract][Full Text] [Related]
25. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
26. Anti-angiogenic cues from vascular basement membrane collagen.
Colorado PC; Torre A; Kamphaus G; Maeshima Y; Hopfer H; Takahashi K; Volk R; Zamborsky ED; Herman S; Sarkar PK; Ericksen MB; Dhanabal M; Simons M; Post M; Kufe DW; Weichselbaum RR; Sukhatme VP; Kalluri R
Cancer Res; 2000 May; 60(9):2520-6. PubMed ID: 10811134
[TBL] [Abstract][Full Text] [Related]
27. Glycosylation-dependent binding of galectin-8 to activated leukocyte cell adhesion molecule (ALCAM/CD166) promotes its surface segregation on breast cancer cells.
Fernández MM; Ferragut F; Cárdenas Delgado VM; Bracalente C; Bravo AI; Cagnoni AJ; Nuñez M; Morosi LG; Quinta HR; Espelt MV; Troncoso MF; Wolfenstein-Todel C; Mariño KV; Malchiodi EL; Rabinovich GA; Elola MT
Biochim Biophys Acta; 2016 Oct; 1860(10):2255-68. PubMed ID: 27130882
[TBL] [Abstract][Full Text] [Related]
28. Cooperative signaling for angiogenesis and neovascularization by VEGF and HGF following islet transplantation.
Golocheikine A; Tiriveedhi V; Angaswamy N; Benshoff N; Sabarinathan R; Mohanakumar T
Transplantation; 2010 Oct; 90(7):725-31. PubMed ID: 20714284
[TBL] [Abstract][Full Text] [Related]
29. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S
Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733
[TBL] [Abstract][Full Text] [Related]
30. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors.
Langenfeld EM; Langenfeld J
Mol Cancer Res; 2004 Mar; 2(3):141-9. PubMed ID: 15037653
[TBL] [Abstract][Full Text] [Related]
31. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.
Dardik R; Inbal A
Exp Cell Res; 2006 Oct; 312(16):2973-82. PubMed ID: 16914140
[TBL] [Abstract][Full Text] [Related]
32. Antiangiogenic activity of beta-eudesmol in vitro and in vivo.
Tsuneki H; Ma EL; Kobayashi S; Sekizaki N; Maekawa K; Sasaoka T; Wang MW; Kimura I
Eur J Pharmacol; 2005 Apr; 512(2-3):105-15. PubMed ID: 15840394
[TBL] [Abstract][Full Text] [Related]
33. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
[TBL] [Abstract][Full Text] [Related]
34. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
[TBL] [Abstract][Full Text] [Related]
35. Decorin suppresses tumor cell-mediated angiogenesis.
Grant DS; Yenisey C; Rose RW; Tootell M; Santra M; Iozzo RV
Oncogene; 2002 Jul; 21(31):4765-77. PubMed ID: 12101415
[TBL] [Abstract][Full Text] [Related]
36. IL-3 affects endothelial cell-mediated smooth muscle cell recruitment by increasing TGF beta activity: potential role in tumor vessel stabilization.
Dentelli P; Rosso A; Calvi C; Ghiringhello B; Garbarino G; Camussi G; Pegoraro L; Brizzi MF
Oncogene; 2004 Mar; 23(9):1681-92. PubMed ID: 14755254
[TBL] [Abstract][Full Text] [Related]
37. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
[TBL] [Abstract][Full Text] [Related]
38. Different angioregulatory activity of monovalent galectin-9 isoforms.
Aanhane E; Schulkens IA; Heusschen R; Castricum K; Leffler H; Griffioen AW; Thijssen VL
Angiogenesis; 2018 Aug; 21(3):545-555. PubMed ID: 29500586
[TBL] [Abstract][Full Text] [Related]
39. Vaccarin promotes endothelial cell proliferation in association with neovascularization in vitro and in vivo.
Xie F; Feng L; Cai W; Qiu Y; Liu Y; Li Y; Du B; Qiu L
Mol Med Rep; 2015 Jul; 12(1):1131-6. PubMed ID: 25815517
[TBL] [Abstract][Full Text] [Related]
40. Antitumor effects of in vivo caveolin gene delivery are associated with the inhibition of the proangiogenic and vasodilatory effects of nitric oxide.
Brouet A; DeWever J; Martinive P; Havaux X; Bouzin C; Sonveaux P; Feron O
FASEB J; 2005 Apr; 19(6):602-4. PubMed ID: 15623570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
